RTW Investments, LP 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 06:12 am Sale |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 0 0.000% |
-3,463,201 (Position Closed) |
Filing |
| 2024-02-14 07:38 am Purchase |
2023-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,463,201 6.300% |
378,986 (+12.29%) |
Filing |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,084,215 6.500% |
-837,364 (-21.35%) |
Filing |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,921,579 8.400% |
498,724 (+14.57%) |
Filing |
| 2021-02-12 09:52 am Purchase |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 3,422,855 8.660% |
1,537,855 (+81.58%) |
Filing |
| 2020-06-19 10:36 am Purchase |
2020-06-11 | 13G | Celldex Therapeutics, Inc. CLDX |
RTW Investments, LP | 1,885,000 9.950% |
1,885,000 (New Position) |
Filing |